Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains - Ledesma, MD; Da Silva, JS; Crassaerts, K; Delacourte, A; De Strooper, B; Dotti, CG. (EMBO Rep, 2000)